3 results
To determine the acceptance and usability of the TraumaGameplay (TGP) app in individuals who have experienced a traumatic event within the first five days and the staff members of Slachtofferhulp Nederland (Department Amsterdam) who will deliver the…
To evaluate the long-term safety and tolerability of elsubrutinib and upadacitinib given alone or as the ABBV-599 (elsubrutinib/upadacitinib) combination in SLE subjects who have completed the M19-130 Phase 2 study.
To assess whether the use of the personalized risk assessment tool (PERSARC) is (cost)effective in reducing decisional conflict and increasing informed choices in high-grade extremity STS compared to usual care (co-primary outcomes). In addition, we…